Clinical tapering strategy

Phase 3Small molecule

CCentre Hospitalier Universitaire de Saint Etienne

Clinical tapering strategy is one of 26 small molecule programs targeting Drug. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

DrugRecruiting

DrugPhase 3

Recruiting

Competition

Competitive Landscape

29 competitors in Drug

#DrugCompanyPhaseTrials

Nicorette

Pfizer

Approved

1 2

Inderal

WWyeth-Lederle Vaccines

Approved

1 3

Ketalar

AAultman Health Foundation

Phase 3

1 4

Neupogen

EEastern Cooperative Oncology Group

Phase 3

1 5

Keytruda

Merck & Co.

Phase 2

1 6

Lenvima

Eisai

Phase 2

1 7

Pepcid

KKenvue Brands

Phase 1

7 8

BAY 987519

Bayer

Phase 1

1 9

Clinical tapering strategy

CCentre Hospitalier Universitaire de Saint Etienne

Phase 3

1 10

Sovaldi

Gilead

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Post-ApprovalRecruiting

Drug

NCT06528431

Clinical

Trials by Indication[1]

Drug1 trial

Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study

Recruiting·—·Phase 4·NCT06528431·180 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Clinical tapering strategy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Clinical tapering strategy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Clinical tapering strategy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Centre Hospitalier Universitaire de Saint Etienne company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: CCentre Hospitalier Universitaire de Saint Etienne

Clinical tapering strategy

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Drug1 trial

References

Drug Info

Quick Facts

Related News